Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum

Journal of the American Academy of Dermatology

Volumn 39, Issue 4 I, 1998, Pages 648-650

  Weichert, G ^a   Sauder, D N ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; THALIDOMIDE; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG EFFICACY; HUMAN; LEG PAIN; MALE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN ULCER; ULCER HEALING;

EID: 0031687202     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70020-9     Document Type: Article

References (13)

1. SH Greenberg BV Jegasothy RB Johnson Pyoderma gangrenosum: occurrence with altered cellular immunity and a circulating serum factor Arch Dermatol 118 1982 498 502
2. CB Bentley-Phillips RC Cooper AF Hallet Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum, and impaired phagocytosis Br J Dermatol 106 1982 687 695
3. AK Gupta NH Shear DN Sauder Efficacy of human intravenous immune globulin in pyoderma gangrenosum J Am Acad Dermatol 32 1995 140 141
4. G Wiederrecht E Lam S Hung M Martin N Sigal The mechanism of action of FK-506 and cyclosporin A Ann N Y Acad Sci 696 1993 9 19
5. MJ Tocci DA Matkovich KA Collier P Kwok F Dumont S Lin The immunosuppressant FK506 selectively inhibits expression of early T-cell activation genes J Immunol 143 1989 718 726
6. M Forrest M Jewell G Koo N Sigal FK506 and cyclosporin A: selective inhibition of calcium ionophore-induced polymorphonuclear leukocyte degranulation Biochem Pharmacol 42 1991 1221 1228
7. GB Klintmalm Clinical use of FK 506 in liver transplantation Transplant Proc 28 1996 924 976
8. CM Spencer KL Goa J Gillis Tacrolimus: an update of its pharmacology and its clinical efficacy Drugs 54 1997 925 975
9. K Abu-Elmagd BV Jegasothy CD Ackerman AW Thomson H Rilo N Nikolaidis Efficacy of FK-506 in the treatment of recalcitrant pyoderma gangrenosum Transplant Proc 23 1991 3328 3329
10. HM Cooley D Castelino P McNair DM Russel V Chohan TWH Kay Resolution of pyoderma gangrenosum using tacrolimus (FK-506) Aust NZ J Med 26 1996 238 239
11. FC Powell WPD Su HO Perry Pyoderma gangrenosum: classification and management J Am Acad Dermatol 34 1996 395 399
12. H Aoyama N Tabata M Tanaka Y Uesugi H Tagami Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK 506 ointment Br J Dermatol 133 1995 494 495
13. FK 506 The European Multicentre Psoriasis Study Group systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind placebo-controlled group Arch Dermatol 132 1996 419 423